- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 03.03. | AbbVie pays Gubra $350m upfront to enter obesity field | ||
| 28.02. | Spain agrees to reimburse Orchard's gene therapy Libmeldy | ||
| 28.02. | AbbVie closes on Rinvoq approval in inflamed artery disease | ||
| 28.02. | FDA clears lifesaving feature for Google's Pixel Watch 3 | ||
| 28.02. | Owkin launches ATLANTIS patient data mining project | ||
| 28.02. | Judge blocks mass firings of federal agency workers | ||
| 27.02. | Indivior changes CEO after warning sales will fall in 2025 | ||
| 27.02. | Regeneron tries again with lymphoma bispecific in US | ||
| 27.02. | Kyorin partners Hyfe to develop DTx for chronic cough | ||
| 27.02. | Vaccine sector on edge as HHS cancels flu meeting | ||
| 26.02. | Lilly unveils $27bn reshoring drive around four new plants | ||
| 26.02. | Perlmutter's Eikon raises $351m in major financing round | ||
| 26.02. | Can Keytruda finally break into early head and neck cancer? | ||
| 26.02. | Why non-diabetics using CGM may not be a good idea | ||
| 26.02. | Bayer reveals phase 3 data for improved MRI contrast agent | ||
| 26.02. | Data cues up AZ oral SERD filing in first-line breast cancer | ||
| 25.02. | Rishi Sunak becomes prostate cancer ambassador | ||
| 25.02. | Lilly launches discounted high-strength Zepbound vials in US | ||
| 25.02. | Evidence builds behind Regeneron's deafness gene therapy | ||
| 25.02. | AI tool detects brain lesions linked to epilepsy | ||
| 25.02. | Ex-CDER chief Cavazzoni rejoins Pfizer as CMO | ||
| 24.02. | FDA looks at Opdivo/Yervoy in first-line colorectal cancer | ||
| 24.02. | FDA clears first therapy for rare disease CTX from Mirum | ||
| 24.02. | Pfizer drops Beqvez, leaving its gene therapy cupboard bare | ||
| 24.02. | Pfizer drops Beqvez, leaving gene therapy cupboard bare |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
